Moenomycin complex
Based on 1 Customer Validation
Moenomycin complex is a class of antibacterial agents and PBP inhibitors, with Kd values ranging from 94 nM to 1690 nM against various bacterial PBPs. Moenomycin complex inhibits bacterial growth by blocking the transglycosylase activity of class A penicillin-binding proteins (PBPs). Moenomycin complex is used in the research of bacterial infections.
For research use only. We do not sell to patients.
- Purity : 99.9%
- CAS No.: 11015-37-5
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
All Antibiotic Isoforms
More
Biological Activity
Description
IC50 & Target
Transglycosylase[1]
In Vitro
Moenomycin complex binds to full-length class A PBPs from 16 bacterial species, with Kd values ranging from 94 nM (Enterococcus faecium PBP1) to 1690 nM (Bacillus subtilis PBP1a/1b)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 11015-37-5
-
Appearance Solid
-
Color Off-white to light yellow
-
SMILES
[Moenomycin complex]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
Ethanol : 25 mg/mL (Need ultrasonic and warming)
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Aerobic Bacterial Batch Culture on Broth/Agar
Aerobic bacterial batch culture grows a closed inoculated population in broth or on agar without continuous medium replacement; growth readouts include turbidity/OD for total suspended biomass and colony-forming units for viable cells able to form colonies on agar. OD-based growth curves reflect light scattering by cells, but OD is instrument-, pathlength-, species-, cell-size-, and density-dependent, so OD should be calibrated or interpreted alongside viable counts when quantitative cell density is required.
Purity & Documentation
-
Data Sheet (265 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Moenomycin complex
- 11015-37-5
- Bacterial
- Antibiotic
- Penicillin-binding protein (PBP)
- Helicobacter pylori
- Enterococcus faecalis
- transglycosylase activity
- Escherichia coli PBP1b
- Enterococcus faecium PBP1
- bacterial cell wall synthesis
- Bacillus subtilis PBP1a/1b
- Staphylococcus aureus
- Gram-positive bacteria
- penicillin-binding protein
- Inhibitor
- inhibitor
- inhibit